MEASURES FOR THE TREATMENT AND PREVENTION OF CONCOMITANT CONDITIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality in the modern world, leading to very significant economic and social damage, the level of which is constantly increasing. According to GOLD-2011, the identification and elimination of risk factors is an important step in the prevention and treatment of COPD.
One of the reasons affecting the frequency of exacerbations may be chronic foci of inflammation of the upper respiratory tract (UPD).
Therapeutic correction of these chronic foci of inflammation can have a positive effect on the course of the underlying disease, reducing the number of episodes of exacerbation of COPD.
This article discusses the idea of chronic obstructive pulmonary disease and concomitant rhinosinusitis, their modern methods of diagnosis and treatment.
Keywords
Rhinosinusitis, comorbidity, chronic obstructive pulmonary disease.
References
- Лопатин A.C. Фармакотерапия воспалительных заболеваний околоносовых пазух // Consilium medicum. 2002. № 4. - С. 186-188.
- Овчинников А.Ю., Купреенко И.Г. Комплексное использование препаратов Фексадин и Насобек в лечении аллергического риносинусита. // Тезисы 11 Российского национального конгресса «Человек и лекарство». — М., 2004. — 215 с.
- Свистушкин В.М., Никифорова Г.Н., Овчинников А.Ю., Панякина М.А. Возможности беспункционного лечения гнойных гайморитов // Российская оториноларингология. -2004. № 3. С. 150-152.
- Янов Ю.К., Страчунский JI.C. Антибактериальная терапия синусита у взрослых пациентов // Consilium medicum. 2002, Т. 4, № 9. - С. 448454.
- Adams S., Melo J., Luther M. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of chronic obstructive pulmonary disease // Chest. 2000. Vol. 117. - P. 1345-1352.
- Murphy T.F., Parameswaran G.I. Moraxella catarrhalis, a human respiratory tract pathogen // Clin Infect Dis. 2009 - Vol. 49(1). - P.124-131.